Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial

Peer Review reports

Original Submission
9 Jul 2018	Submitted	Original manuscript
15 Oct 2018	Reviewed	Reviewer Report - Jan De Waele
17 Feb 2019	Reviewed	Reviewer Report - Fekade Bruck Sime
25 Feb 2019	Reviewed	Reviewer Report - Marie Clemence Verdier
18 Mar 2019	Author responded	Author comments - Stefan Hagel
Resubmission - Version 2
18 Mar 2019	Submitted	Manuscript version 2
Publishing
10 May 2019	Editorially accepted
6 Jun 2019	Article published	10.1186/s13063-019-3437-x

Back to article page